Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000914760-17-000007
Filing Date
2017-01-06
Accepted
2017-01-06 17:24:01
Documents
1
Effectiveness Date
2017-01-06
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12936
  Complete submission text file 0000914760-17-000007.txt   13993
Mailing Address 43 THORNDIKE STREET SUITE S1-3 CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET SUITE S1-3 CAMBRIDGE MA 02141 617-758-0300
Neurovance, Inc. (Filer) CIK: 0001544176 (see all company filings)

EIN.: 454090332 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-277876 | Film No.: 17515159